Evidence map›Paper›PMID 32206145›Full record

ArticleHereditary cancer in clinical practice2020

An interesting case of likely

Lučka Boltežar, Gorana Gašljević, Srdjan Novaković, Vida Stegel, Erik Škof

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Hereditary cancer in clinical practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lučka Boltežar1Division of Medical Oncology, Institute of Oncology Ljubljana, Zaloska cesta 2, 1000 Ljubljana, Slovenia.
Gorana Gašljević2Department of Pathology, Institute of Oncology Ljubljana, Zaloska cesta 2, 1000 Ljubljana, Slovenia.
Srdjan Novaković3Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Zaloska cesta 2, 1000 Ljubljana, Slovenia.
Vida Stegel3Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Zaloska cesta 2, 1000 Ljubljana, Slovenia.
Erik Škof1Division of Medical Oncology, Institute of Oncology Ljubljana, Zaloska cesta 2, 1000 Ljubljana, Slovenia.
Institute of Oncology Ljubljana · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn a patient with a germline CASE PRESENTATION: We present a case of a 47-year-old patient with bilateral breast carcinoma with a germline

conclusionWe present an interesting and quite rare case of two primary breast carcinomas in a patient with a known

Indexed as

BRCA2Breast cancerFimbrial part of fallopian tubeOligometastaticReceptor conversion

Identifiers

PMID32206145
PMCPMC7081695
OpenAlexW3012676436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.